Dr Reddys Laboratories (RDY) Cash from Operations (2009)
Dr Reddys Laboratories (RDY) posted quarterly Cash from Operations of 58000000.0 for Q4 2009, down 36.96% quarter-over-quarter from 92000000.0 in Q3 2009.
Dr Reddys Laboratories (RDY) Cash from Operations (2009) Analysis & Trends
Dr Reddys Laboratories' Cash from Operations history runs 1 years deep, the most recent figure standing at 58000000.0 for Q4 2009.
- In Q4 2009, Cash from Operations changed N/A year-over-year to 58000000.0; the TTM figure through Dec 2009 stood at 236316000.0 (changed N/A YoY), while the FY2026 annual figure was 607000000.0, up 11.38% from the prior year.
- Cash from Operations for Q4 2009 stood at 58000000.0, down from 92000000.0 in the prior quarter.
- The five-year high for Cash from Operations was 96000000.0 in Q2 2009, with the low at 58000000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 145.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 58.00 Mn |
| Dec 31, 2009 | 58.00 Mn |
| Sep 30, 2009 | 92.00 Mn |
| Sep 30, 2009 | 92.00 Mn |
| Jun 30, 2009 | 96.00 Mn |
| Jun 30, 2009 | 96.00 Mn |